American Healthcare REIT (AHR) Cost of Revenue (2017 - 2026)

American Healthcare REIT (AHR) has reported Cost of Revenue for 10 consecutive years, with $524.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 23.12% year-over-year to $524.8 million; the trailing twelve-month figure through Jun 2026 stood at $2.0 billion (up 15.55% YoY), and the FY2025 full-year result was $1.8 billion, up 8.44% from the prior year.
• Cost of Revenue climbed to $524.8 million in Q2 2026 per AHR's latest filing, from $512.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $524.8 million in Q2 2026 and bottomed at $287.2 million in Q1 2022.
• Historically, Cost of Revenue has averaged $403.8 million across 5 years, with a median of $403.1 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue jumped 31.41% in 2022, then advanced 5.89% in 2025.
• Over 5 years, Cost of Revenue stood at $360.8 million in 2022, then grew by 6.7% to $385.0 million in 2023, then gained by 11.83% to $430.6 million in 2024, then rose by 11.55% to $480.3 million in 2025, then rose by 9.27% to $524.8 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $524.8 million, $512.2 million, and $480.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.